Linked Life Data

48887Pathway480

Source:http://www.reactome.org/biopax/48887Pathway480

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
biopax3:comment
Authored: Rothfels, K, 2012-02-09, Edited: Rothfels, K, 2012-05-16, Reviewed: Ezzat, S, 2012-05-15, Unlike other FGFR2 and 3, FGFR1 appears not to be a frequent target of activating point mutations (reviewed in Wesche, 2011; Turner and Grose, 2010). Germline point mutations at residue P252 have been identified in Pfeiffer syndrome (reviewed in Webster and Donoghue, 1997; Burke, 1998; Cunningham, 2007) while mutation of the same residue arising somatically has been identified in melanoma and lung cancer (Ruhe, 2007; Davies, 2005). Two kinase domain mutations have been characterized in glioblastoma (Rand, 2005; Network TCGA, 2008), both at positions that are also mutated in an autosomal disorder in one of the FGFR family members (Muenke, 1994; Bellus, 1995a; Bellus, 2000; Tavormina, 1995a; Tavormina, 1999).
biopax3:xref
biopax3:dataSource
biopax3:displayName
Signaling by activated point mutants of FGFR1
biopax3:organism
biopax3:pathwayComponent
biopax3:pathwayOrder